Literature DB >> 7740945

Size and timing of local recurrence predicts metastasis in soft tissue sarcoma. Growth rate index retrospectively analyzed in 134 patients.

P F Choong1, P Gustafson, A Rydholm.   

Abstract

Our study combined size and timing of the first local recurrence to create a growth rate index (GRI-ratio of size (cm) to timing (mo)) which we analyzed for an association with metastasis. We analyzed 134 locally recurrent tumors from a series of 460 adult patients with soft tissue sarcoma of the extremities and trunk wall who were diagnosed and treated between 1964 and 1990, with a median follow-up of 10 (2-28) years for survivors. None of the patients had metastases at diagnosis. One half (74) of local recurrences were from inadequately treated primaries, one half (71) were associated with metastases, and two thirds (89) were seen in non-center-treated patients. There were equal numbers of patients with GRI < or = 0.4 (low) and > 0.4 (high). Patients with a low GRI had a better 2-year metastasis-free survival (80 percent) than those with a high GRI (30 percent). High GRIs were associated with large, high grade primary tumors and a short metastasis-free interval in comparison to low GRI tumors. Time to local recurrence strongly correlated with the time to metastasis (R2 0.85, p < 0.001). GRI was a good discriminator of metastasis in patients with tumors larger than 5 cm and of malignancy grade IV. Our study suggests that clinical characteristics (e.g., GRI) of local recurrence rather than presence, per se, are important in predicting tumor behavior.

Entities:  

Mesh:

Year:  1995        PMID: 7740945     DOI: 10.3109/17453679508995509

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  4 in total

Review 1.  Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG).

Authors: 
Journal:  Ann Oncol       Date:  2018-04-01       Impact factor: 32.976

2.  Does size reliably predict malignancy in soft tissue tumours?

Authors:  Leonhard Gruber; Alexander Loizides; Laurin Ostermann; Bernhard Glodny; Michaela Plaikner; Hannes Gruber
Journal:  Eur Radiol       Date:  2016-03-09       Impact factor: 5.315

3.  Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out?

Authors:  Sarantis Abatzoglou; Robert E Turcotte; Abdurahman Adoubali; Marc H Isler; David Roberge
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

4.  Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience.

Authors:  A Llombart-Cussac; X Pivot; G Contesso; A Rhor-Alvarado; J P Delord; M Spielmann; T Türsz; A Le Cesne
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.